The next-generation Watchman FLX left atrial appendage occlusion device has received US Food and Drug Administration approval, device maker Boston Scientific announced Tuesday. “We will initiate a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback